Hypercoagulable State in COVID-19: A Case Series of Three Patients
covid-19, sars-cov-2, novel coronavirus, hypercoagulable, prothrombotic, acute pulmonary embolism, dvt, venous thromboembolsim
Cardiovascular Diseases | Emergency Medicine | Hematology | Infectious Disease | Virus Diseases
The novel coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that originated in China in late 2019, has caused significant morbidity and mortality worldwide. Although fever, cough, and shortness of breath have been recognized as hallmark symptoms, other lesser known complications continue to be described. We report a series of three patients who presented to the emergency department, who tested positive for COVID-19, and were found to have or subsequently developed thromboembolic complications.
Publisher or Conference
Logan G, Dub L, Drone E, et al. (June 27, 2020) Hypercoagulable State in COVID-19: A Case Series of Three Patients. Cureus 12(6): e8872. doi:10.7759/cureus.8872